Article
Drug resistance in antiviral therapy.
Clinics in liver disease - 1 Aug 2010
Locarnini Stephen, Bowden Scott
Abstract excerpt
The introduction of nucleos(t)ide analog therapy has seen the emergence of antiviral drug resistance, which has become the main factor limiting the long-term application of these antiviral agents for patients with chronic hepatitis B. The prevention of resistance requires the adoption of strategies that effectively control virus replication and exploit an understanding of the mechanisms and processes that drive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
